drugset / Trial / NCT05598281
Study to Evaluate the Effect of AMG 510 on the Pharmacokinetics (PK) of Digoxin in Healthy Participants
NaSingle-groupOpen-labelBasic science
Summary
The primary objective of the study is to evaluate the PK of digoxin administered alone and in combination with AMG 510 in healthy participants.
Timeline
- Start
- 2019-11-05
- Primary completion
- 2019-11-19
- Completion
- 2019-11-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Digoxin | Other / unclassified | 0.5 mg | Oral |
| Subject | Sotorasib | Small molecule | 960 mg | Oral |
Indications
No indication recorded.